CG Oncology, Inc.
CGON
$19.28
$1.659.36%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 742.00M | 540.71M | 552.88M | 566.51M | 187.67M |
Total Receivables | 781.00K | 137.00K | 182.00K | 153.00K | 92.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 11.43M | 11.23M | 10.80M | 11.95M | 6.36M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 754.21M | 552.08M | 563.86M | 578.61M | 194.12M |
|
|||||
Total Current Assets | 754.21M | 552.08M | 563.86M | 578.61M | 194.12M |
Net Property, Plant & Equipment | 493.00K | 338.00K | 413.00K | 445.00K | 491.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 94.00K | 53.00K | 53.00K | 53.00K | 4.69M |
Total Assets | 754.80M | 552.47M | 564.33M | 579.11M | 199.30M |
|
|||||
Total Accounts Payable | 6.52M | 4.08M | 4.49M | 4.66M | 3.24M |
Total Accrued Expenses | 14.23M | 11.11M | 6.99M | 4.82M | 9.68M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 186.00K | 225.00K | 237.00K | 220.00K | 217.00K |
Total Finance Division Other Current Liabilities | 436.00K | 221.00K | 131.00K | 282.00K | 1.12M |
Total Other Current Liabilities | 436.00K | 221.00K | 131.00K | 282.00K | 1.12M |
Total Current Liabilities | 21.37M | 15.63M | 11.85M | 9.98M | 14.25M |
|
|||||
Total Current Liabilities | 21.37M | 15.63M | 11.85M | 9.98M | 14.25M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 52.00K | 71.00K | 118.00K | 184.00K | 244.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 13.00K |
Total Liabilities | 21.42M | 15.70M | 11.97M | 10.17M | 14.51M |
|
|||||
Common Stock & APIC | 951.36M | 722.95M | 718.14M | 715.81M | 6.84M |
Retained Earnings | -217.98M | -186.18M | -165.78M | -146.87M | -129.94M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 733.38M | 536.77M | 552.36M | 568.94M | -123.10M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | 307.89M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | 307.89M |
|
|||||
Total Common Equity | 733.38M | 536.77M | 552.36M | 568.94M | -123.10M |
Total Preferred Equity | -- | -- | -- | -- | 307.89M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 733.38M | 536.77M | 552.36M | 568.94M | 184.79M |
|